Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Condition:   Hypertension, Dyslipidemia Interventions:   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug) Sponsor:   Daewoong Pharmaceutical Co. LTD. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials